- Patent Title: Method for treating lupus by administering an anti-IL-12 antibody
-
Application No.: US16677120Application Date: 2019-11-07
-
Publication No.: US11078267B2Publication Date: 2021-08-03
- Inventor: Jill Giles-Komar , David M. Knight , David Peritt , Bernard Scallon , David Shealy
- Applicant: Janssen Biotech, Inc.
- Applicant Address: US PA Horsham
- Assignee: Janssen Biotech, Inc.
- Current Assignee: Janssen Biotech, Inc.
- Current Assignee Address: US PA Horsham
- Agent Eric Dichter
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/24 ; A61K45/06 ; A61K39/00
Abstract:
Isolated anti-IL-12 antibodies, nucleic acids encoding antibodies or antibody portions, vectors, host cells, and methods of making are useful for production of antibody or portions for treating and/or diagnosing IL-12 related conditions, diseases, and disorders, such as systemic lupus erythematosus.
Public/Granted literature
- US20200062841A1 Method for Treating Lupus By Administering An Anti-IL-12 Antibody Public/Granted day:2020-02-27
Information query
